CN101032599A - 驻颜美容瘦身养生液 - Google Patents
驻颜美容瘦身养生液 Download PDFInfo
- Publication number
- CN101032599A CN101032599A CNA2007100720197A CN200710072019A CN101032599A CN 101032599 A CN101032599 A CN 101032599A CN A2007100720197 A CNA2007100720197 A CN A2007100720197A CN 200710072019 A CN200710072019 A CN 200710072019A CN 101032599 A CN101032599 A CN 101032599A
- Authority
- CN
- China
- Prior art keywords
- parts
- fructus
- present
- conditioning skin
- losing weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000003750 conditioning effect Effects 0.000 title claims description 6
- 241000208340 Araliaceae Species 0.000 claims abstract description 9
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 9
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 9
- 235000008434 ginseng Nutrition 0.000 claims abstract description 9
- 210000000582 semen Anatomy 0.000 claims description 12
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 8
- 244000293323 Cosmos caudatus Species 0.000 claims description 7
- 235000005956 Cosmos caudatus Nutrition 0.000 claims description 7
- 108010052008 colla corii asini Proteins 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 7
- 230000000694 effects Effects 0.000 abstract description 17
- 230000036541 health Effects 0.000 abstract description 11
- 230000006870 function Effects 0.000 abstract description 5
- 230000008901 benefit Effects 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract description 2
- 244000068645 Carya illinoensis Species 0.000 abstract 1
- 235000009025 Carya illinoensis Nutrition 0.000 abstract 1
- 241000234435 Lilium Species 0.000 abstract 1
- 235000012907 honey Nutrition 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 230000000474 nursing effect Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 230000003796 beauty Effects 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 5
- 206010020772 Hypertension Diseases 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- 229910052791 calcium Inorganic materials 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 4
- 208000031226 Hyperlipidaemia Diseases 0.000 description 4
- 241000545442 Radix Species 0.000 description 4
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 4
- 206010022437 insomnia Diseases 0.000 description 4
- 150000007524 organic acids Chemical class 0.000 description 4
- 108010048734 sclerotin Proteins 0.000 description 4
- 208000002874 Acne Vulgaris Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 206010057315 Daydreaming Diseases 0.000 description 3
- 206010028372 Muscular weakness Diseases 0.000 description 3
- 208000008589 Obesity Diseases 0.000 description 3
- 206010000496 acne Diseases 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 230000002124 endocrine Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000036473 myasthenia Effects 0.000 description 3
- 231100000957 no side effect Toxicity 0.000 description 3
- 235000020824 obesity Nutrition 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 208000007443 Neurasthenia Diseases 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- MDZKJHQSJHYOHJ-UHFFFAOYSA-N crataegolic acid Natural products C1C(O)C(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MDZKJHQSJHYOHJ-UHFFFAOYSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 210000003494 hepatocyte Anatomy 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- MDZKJHQSJHYOHJ-LLICELPBSA-N maslinic acid Chemical compound C1[C@@H](O)[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MDZKJHQSJHYOHJ-LLICELPBSA-N 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- YEFOAORQXAOVJQ-RZFZLAGVSA-N schisandrol a Chemical compound C1[C@H](C)[C@@](C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-RZFZLAGVSA-N 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- DHHFDKNIEVKVKS-FMOSSLLZSA-N Betanin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC(C[C@H]2C([O-])=O)=C1[N+]2=C\C=C\1C=C(C(O)=O)N[C@H](C(O)=O)C/1 DHHFDKNIEVKVKS-FMOSSLLZSA-N 0.000 description 1
- DHHFDKNIEVKVKS-MVUYWVKGSA-N Betanin Natural products O=C(O)[C@@H]1NC(C(=O)O)=C/C(=C\C=[N+]/2\[C@@H](C(=O)[O-])Cc3c\2cc(O)c(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)c3)/C1 DHHFDKNIEVKVKS-MVUYWVKGSA-N 0.000 description 1
- 241000283074 Equus asinus Species 0.000 description 1
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000012677 beetroot red Nutrition 0.000 description 1
- 239000001654 beetroot red Substances 0.000 description 1
- 235000002185 betanin Nutrition 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000000527 lymphocytic effect Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000001995 reticulocyte Anatomy 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 229930193195 schizandrin Natural products 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- YEFOAORQXAOVJQ-UHFFFAOYSA-N wuweizischun A Natural products C1C(C)C(C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供了一种驻颜美容瘦身养生液。它是由重量比为:人参10-15份、大枣20-30份、山楂20-30份、百合10-20份、山核桃仁10-20份、黄精10-30份、阿胶10-20份、首乌10-20份、韭菜子20-30份、五味子10-20份、珍珠粉15-30份、蜂蜜15-30份制成。本发明集滋养、保健、美容、养颜、瘦身于一体,具有见效快、纯天然、无毒副作用等优点。
Description
(一)技术领域
本发明涉及保健领域,具体涉及一种用于驻颜美容的药酒。
(二)背景技术
目前市场上针对美容养颜瘦身的保健品品种繁多,但多数产品化学添加剂多、副作用大、见效慢,并且瘦身产品经常会扰乱人体内环境,破坏人体内平衡,并且会出现反弹,对人体健康存在威胁。而能集滋养、保健、美容、养颜、瘦身于一体的保健品却不多见。中药一直以其副作用小、天然等优点为人们信赖,但针对滋养、保健、美容、养颜、瘦身的中药制剂却少之又少。因而市场上非常缺乏一种无毒副作用、纯天然、保健疗效显著的中医保健品。
(三)发明内容
本发明的目的在于提供一种能集滋养、保健、美容、养颜、瘦身于一体的,见效快、纯天然、无毒副作用的驻颜美容瘦身养生液。
本发明的目的是这样实现的:它是由重量比为:人参10-15份、大枣20-30份、山楂20-30份、百合10-20份、山核桃仁10-20份、黄精10-30份、阿胶10-20份、首乌10-20份、韭菜子20-30份、五味子10-20份、珍珠粉15-30份和蜂蜜15-30份制成。
本发明还有这样一些技术特征:
1、它还包括按重量比为茯苓20-30份、鹿茸6-10份和枸杞6-10份。
本发明配制时先将各原料用纱、布袋包好,放入60°优质白酒中浸泡20-40天,过滤后用28-42±1%(V/V)乙醇调酒度,质检后然后经过瞬间灭菌后独立包装。
本发明的设计方案源于祖国传统医学中关于“扶正祛邪”、“补虚不致滞邪,攻邪不致伤正”的辨证论治思想,是发明设计人通过对古今医药著作潜心研究并再总结设计者多年临床行医实践基础上应用传统中草药精心加工制成的一种纯中药药酒。它以十二味中药为基本配方,经过科学炮制而成。
在药物配方中,人参补元气,补肺气,补脾生津,还能促进人体细胞发育,据美国学者海弗利克研究认为,人体细胞大约分裂50次就停止了,人的生命也因之结束,经实验证明,长期服用适量的人参能增加细胞分裂的次数并延长寿命;黄精补脾肾,益虚损,润肺止咳,黄精含生物碱、皂甙、强心甙等成分,据研究实验发现,黄精具有提高人体T淋巴细胞的作用,还有降血糖、降胆固醇的功效,不但能够美容、瘦身,同时对防止中老年人常见的心血管、糖尿病都有一定的作用;首乌含蒽醌的微生物、卵磷脂以及肾上腺皮质类物质,对动脉硬化、高血压、冠心病、高血脂症以及心胸供血不足者有一定疗效,同时还能提高T淋巴细胞的功能和增加人体免疫功能;阿胶是驴皮熬制而成,含有多种氨基酸、钙、硫等成分,它有加速红细胞,血红蛋白生成的作用,可以改善体内钙的平衡,促进钙的吸收,还有止血作用;大枣含有蛋白质,糖类,有机酸,维生素(A、B、C),微量元素(钙、磷、铁)等成分,能润肠通便;山楂含脂肪酶和山楂酸,脂肪酶可促进脂肪分解,山楂酸能提高蛋白酶活性;百合具有润肺止咳,清心安神功效;珍珠粉可以健肌肤,美容颜,适用于女性性功能低下,皮肤粗糙,产后虚弱,肺痨咳嗽,盗汗,神经衰弱等症;五味子含有五味子素及多种有机酸,具有防治神经衰弱,失眠健忘等作用;蜂蜜中含葡萄糖,果糖,蔗糖,多种氨基酸,有机酸,酶素,芳香物质,维生素(B1、B6、AKC),生物雌激素,47种微量元素(钙、钾、镁、硒等)等成份,临床证明对心脏病,高血压,肝脏病,贫血,胃,十二指肠溃疡,肺病以及神经系统都有很好的治疗作用。
本发明在祖传秘方的基础上,经过多例患者的服用与临床验证,不断探索总结,改进形成,配方比较完整,疗效确切。另外,本发明在主方基础上增加适量茯苓、鹿茸和枸杞,茯苓含有麦角淄醇,多糖类,有机酸,有机碱,脂肪油等成分,能改善神经、消化、循环、呼吸等功能,并能降血脂,抗肿瘤;鹿茸含骨质,胶质,蛋白质及极少量的女性卵胞激素,还能使血红细胞、血红蛋白、网状红细胞增生,所以能温肾、强筋骨、补气血、解疮毒;枸杞含有甜菜碱、多种不饱和脂肪酸、氨基酸、维生素等成分,并能抑制脂肪在肝细胞内沉积,促进肝细胞新生,可防止肝硬化,并有明显的降血糖、降血压疗效,对眼疾病等有防治作用,这些辅料配合主配方集滋养、保健、美容、养颜、瘦身于一体,具有见效快、纯天然、无毒副作用等优点。
本发明经两组临床验证,其中一组为治疗组服用本发明制剂,每日服3次,每次口服25毫升,21天为1个疗程,另一组为对照组服用三菇美容女士酒,每组选择中青年妇女86例,最大年龄65岁,最小年龄27岁,每日服3次,每次口服25毫升,21天为1个疗程,临床表现为四肢无力、面色灰暗、精神恍惚、失眠、多梦、便秘、内分泌失调、气血不周、骨质透风、肥胖症、高血压、高血脂、痤疮,表1为服用1个疗程后的对照数据:
表1 服用前后两组疗程比较(单位:人)
体征 | 对照组 | 治疗组 | ||||
服药前 | 服药后有效人数 | 有效率% | 服药前 | 服药后有效人数 | 有效率% | |
四肢无力 | 3 | 2 | 66.7 | 5 | 4 | 80 |
面色灰暗 | 15 | 9 | 60 | 16 | 14 | 87.5 |
精神恍惚 | 25 | 12 | 48 | 24 | 20 | 83.3 |
失眠 | 25 | 11 | 44 | 12 | 11 | 91.7 |
多梦 | 26 | 20 | 76.9 | 30 | 26 | 86.7 |
便秘 | 22 | 12 | 54.5 | 15 | 14 | 93.3 |
内分泌失调 | 12 | 9 | 75 | 21 | 20 | 95.2 |
气血不周 | 24 | 21 | 87.5 | 20 | 17 | 85 |
骨质透风 | 21 | 11 | 52.4 | 24 | 20 | 83.3 |
肥胖症 | 23 | 12 | 52.1 | 25 | 22 | 88 |
高血压 | 30 | 14 | 46 | 30 | 28 | 93.3 |
高血脂 | 30 | 18 | 60 | 30 | 25 | 83.3 |
痤疮 | 15 | 9 | 60 | 24 | 20 | 83.3 |
治疗组和对照组有显著差异,从而可以看出本发明在临床上的应用有显著的疗效。
(四)具体实施方式
下面结合具体实施例对本发明作进一步的说明:
实施例1:适用于四肢无力、面色灰暗、精神恍惚、失眠、多梦人群
本实施例由重量比为:人参12份、大枣24份、山楂24份、百合12份、山核桃仁12份、黄精24份、阿胶12份、首乌12份、韭菜子24份、五味子12份、珍珠粉24份、蜂蜜24份和茯苓24份、鹿茸8份、枸杞8份组成。
本实施例配制时先将各原料用纱、布袋包好,放入60°优质白酒中浸泡30天,过滤后用28-42±1%(V/V)乙醇调酒度,质检后然后经过瞬间灭菌后独立包装。
实施例2:适用于便秘、内分泌失调、气血不周人群
本实施例由重量比为:人参14份、大枣25份、山楂25份、百合20份、山核桃仁20份、黄精25份、阿胶20份、首乌15份、韭菜子25份、五味子15份、珍珠粉15份、蜂蜜30份和茯苓25份、鹿茸6份、枸杞10份组成。
本实施例配制过程同实施例1。
实施例3:适用于骨质透风、痤疮人群
本实施例由重量比为:人参15份、大枣20份、山楂20份、百合20份、山核桃仁20份、黄精26份、阿胶16份、首乌16份、韭菜子22份、五味子15份、珍珠粉25份、蜂蜜18份和茯苓20份、鹿茸6份、枸杞6份组成。
本实施例配制过程同实施例1。
实施例4:适用于肥胖症、高血压、高血脂人群
本实施例由重量比为:人参12份、大枣20份、山楂30份、百合12份、山核桃仁12份、黄精25份、阿胶12份、首乌12份、韭菜子25份、五味子15份、珍珠粉15份、蜂蜜155-30份和茯苓25份、鹿茸10份、枸杞10份组成。
本实施例配制过程同实施例1。
Claims (2)
1、一种驻颜美容瘦身养生液,其特征在于它是由重量比为:人参10-15份、大枣20-30份、山楂20-30份、百合10-20份、山核桃仁10-20份、黄精10-30份、阿胶10-20份、首乌10-20份、韭菜子20-30份、五味子10-20份、珍珠粉15-30份、蜂蜜15-30份制成。
2、根据权利要求1所述的驻颜美容瘦身养生液,其特征在于它还包括重量比为:茯苓20-30份、鹿茸6-10份和枸杞6-10份。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007100720197A CN101032599B (zh) | 2007-04-10 | 2007-04-10 | 驻颜美容瘦身养生液 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007100720197A CN101032599B (zh) | 2007-04-10 | 2007-04-10 | 驻颜美容瘦身养生液 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101032599A true CN101032599A (zh) | 2007-09-12 |
CN101032599B CN101032599B (zh) | 2010-04-21 |
Family
ID=38729465
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2007100720197A Active CN101032599B (zh) | 2007-04-10 | 2007-04-10 | 驻颜美容瘦身养生液 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101032599B (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101214216B (zh) * | 2008-01-14 | 2011-10-05 | 北京中科雍和医药技术有限公司 | 一种美白精油面膜 |
CN102630955A (zh) * | 2012-03-27 | 2012-08-15 | 池州市德余食品有限公司 | 一种养颜板鸭的制备方法 |
CN103371383A (zh) * | 2013-07-26 | 2013-10-30 | 哈尔滨膳宝酒业有限公司 | 珍珠阿胶美容养颜汤料的配方及其生产方法 |
CN103436417A (zh) * | 2013-09-03 | 2013-12-11 | 孟宗科 | 一种保健酒及其制备方法 |
CN106421519A (zh) * | 2016-10-17 | 2017-02-22 | 新化县唐奇中药材种植专业合作社 | 一种保健药酒 |
CN109010459A (zh) * | 2018-09-21 | 2018-12-18 | 湖北吉登丰生物技术有限公司 | 一种强身泰中药组合物 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100350969C (zh) * | 2003-12-31 | 2007-11-28 | 赵恒� | 一种具有美容养颜作用的冲剂 |
CN1772227A (zh) * | 2005-11-04 | 2006-05-17 | 张开钧 | 人体平衡素中药制剂及制备工艺 |
-
2007
- 2007-04-10 CN CN2007100720197A patent/CN101032599B/zh active Active
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101214216B (zh) * | 2008-01-14 | 2011-10-05 | 北京中科雍和医药技术有限公司 | 一种美白精油面膜 |
CN102630955A (zh) * | 2012-03-27 | 2012-08-15 | 池州市德余食品有限公司 | 一种养颜板鸭的制备方法 |
CN102630955B (zh) * | 2012-03-27 | 2013-09-11 | 池州市德余食品有限公司 | 一种养颜板鸭的制备方法 |
CN103371383A (zh) * | 2013-07-26 | 2013-10-30 | 哈尔滨膳宝酒业有限公司 | 珍珠阿胶美容养颜汤料的配方及其生产方法 |
CN103436417A (zh) * | 2013-09-03 | 2013-12-11 | 孟宗科 | 一种保健酒及其制备方法 |
CN106421519A (zh) * | 2016-10-17 | 2017-02-22 | 新化县唐奇中药材种植专业合作社 | 一种保健药酒 |
CN109010459A (zh) * | 2018-09-21 | 2018-12-18 | 湖北吉登丰生物技术有限公司 | 一种强身泰中药组合物 |
Also Published As
Publication number | Publication date |
---|---|
CN101032599B (zh) | 2010-04-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103263608B (zh) | 一种排毒养颜的中药原粉 | |
CN102172269B (zh) | 一种具有美容作用阿胶组合食品 | |
CN101721565B (zh) | 一种蜂产品保健品及其制备方法 | |
CN101032599B (zh) | 驻颜美容瘦身养生液 | |
CN104740541B (zh) | 一种保肝解毒恢复肝功能的保健中药粉 | |
CN1772196A (zh) | 一种调节心衰的中药药物 | |
CN105497261A (zh) | 一种外用贴剂基质及该基质制成的外用贴剂和助眠贴 | |
CN100542579C (zh) | 一种治疗冠心病的养心胶囊 | |
CN101036721A (zh) | 鹿胎软胶囊及其制造方法 | |
CN105687480A (zh) | 一种免疫调节的中药组合物及制剂 | |
CN105796981A (zh) | 用于改善亚健康状态的中药口服液及其制备方法 | |
CN103156956B (zh) | 一种补血口服液及制备方法 | |
CN1836716A (zh) | 一种保健口服液 | |
CN1234393C (zh) | 一种用于治疗原发性低血压病的中成药 | |
CN105663900B (zh) | 一种用于改善肝硬化营养状态的药膳 | |
CN107125751A (zh) | 龟粉、制备方法及其应用 | |
CN102973687B (zh) | 调节妇女内分泌平衡的口服液 | |
CN101884760B (zh) | 一种治疗糖尿病的中药组合物及其制备方法 | |
CN106729304B (zh) | 一种减轻禁食或节食副反应的中药及其制备方法 | |
CN104740579B (zh) | 经前安片及其制备工艺 | |
CN108310212A (zh) | 一种用于延缓衰老的药物及其制备方法和应用 | |
CN109758559A (zh) | 一种治疗慢性疲劳综合征的中药组合物及其制备方法和应用 | |
CN1059583C (zh) | 用于治疗中医虚证的中药口服液 | |
CN102783645B (zh) | 用于提高免疫力的保健品 | |
CN105941773A (zh) | 一种保健茶及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220721 Address after: 150302 Chengjian village, Hedong street, Acheng District, Harbin City, Heilongjiang Province (opposite to Hedong police station) Patentee after: HARBIN LING CHUN WEI DAO FOOD DEVELOPMENT Co.,Ltd. Address before: 150302, Lin Road, Hedong District, A Cheng District, Heilongjiang, Harbin, 99 Patentee before: Yin Fengqin |